Thought Leadership

5 Must-Knows for Extracting Protein, DNA, and RNA from a Single Sample

A single sample can reveal a more complete picture of disease across DNA, RNA, and protein

Written byMalin Karlsson, PhD
| 3 min read
Generating these layers of information from a single input requires deliberate decisions at the extraction stage.
Register for free to listen to this article
Listen with Speechify
0:00
3:00

In research laboratories, some of the most consequential decisions are made at the very start of a workflow. How a sample is handled in those first steps influences more than yield. It shapes the integrity of the insights that follow.

This is particularly true when investigators aim to generate DNA, RNA, and protein data from the same specimen. Patient-derived samples are often small and rarely uniform. A single biopsy may contain multiple cell types and distinct molecular profiles. 

At the same time, scientific questions have evolved beyond identifying mutations to understanding how those changes influence gene expression and protein activity.

Generating these layers of information from a single input requires deliberate decisions at the extraction stage. 

Consider these five factors when deciding whether to generate DNA, RNA, and proteins from a single sample:

1. Preserve biological continuity 

Limited and heterogeneous samples make it difficult to divide material across separate protein, DNA, and RNA workflows without introducing variability. Tumor biopsies and other patient-derived specimens often contain mixed cell populations and spatial heterogeneity, a well-documented challenge in cancer research. Even small differences in how material is allocated can influence downstream interpretation. Extracting protein, DNA, and RNA from the same preparation ensures that each dataset reflects the same cells and conditions, supporting more reliable and comprehensive comparisons.

2. Design for integration, not parallel workflows 

The value of multi-omics analysis lies in how molecular layers are interpreted together. Downstream comparisons should be considered at the outset. If the goal is to correlate mutations with gene expression and protein activity, extraction strategies should preserve alignment across those layers. Planning for integration early reduces the need to reconcile discrepancies later and supports a more coherent interpretation of multi-omics data.

It’s also worth recognizing that while DNA and RNA purification workflows have become standardized across research laboratories, protein extraction methods remain more variable. When protein is processed separately from nucleic acids, inconsistencies in preparation can complicate direct comparisons across molecular layers. For multi-omics studies seeking to connect genetic variation to functional protein outcomes, greater attention to how the protein layer is recovered from the same biological context is increasingly important.

3. The growing reality of small biopsies and rare cell populations

Advances in minimally invasive procedures and precision medicine have increased reliance on small biopsies, fine-needle aspirates, and highly specific cell populations. These samples are often limited in volume and represent narrowly defined biological contexts, such as a particular treatment timepoint or tumor subtype. Extraction strategies must therefore be designed to generate multiple layers of molecular insight from constrained input.

4. Automation and reproducibility in modern sample preparation 

As multi-omics studies expand in scale and complexity, consistency in sample handling becomes increasingly important. Variability introduced during extraction can compound during downstream analysis, particularly when integrating genomic, transcriptomic, and proteomic datasets. Standardized and automated workflows can help reduce operator-dependent variability and improve consistency across samples and batches. Reproducibility at the extraction stage is essential to maintaining confidence in the data.

5. Consider the broader implications for cancer and disease research 

The ability to analyze DNA, RNA, and protein from a single specimen has implications beyond workflow efficiency. In cancer and complex disease research, understanding how genetic variation influences gene expression and protein activity is essential to building a more complete picture of disease biology. When multiple molecular layers can be derived from the same biological context, researchers are better positioned to identify meaningful relationships and generate hypotheses grounded in integrated data. As multi-omics approaches continue to expand, thoughtful extraction strategies will play an increasingly important role in shaping the quality and interpretability of research findings.

Researchers are often asked to do more with less: smaller samples, shorter timelines, and fewer resources. Being able to analyze DNA, RNA, and protein from a single sample, even if it’s small, can help deepen our understanding of how diseases develop and transform.

Add Today's Clinical Lab as a preferred source on Google

Add Today's Clinical Lab as a preferred Google source to see more of our trusted coverage.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...